The STEP clinical trial program, which evaluated higher doses of semaglutide (2.4 mg weekly) for chronic weight management, demonstrated significantly higher rates of vomiting, with approximately 20-25% of participants reporting this adverse effect during the study period
In the realm of diabetes care, semaglutide plays a crucial role in improving insulin sensitivity, reducing A1C levels (an important marker of long-term blood sugar control), and even decreasing the risk of cardiovascular complications
Haberland A, Mller J (2022) Lack of efficacy of mono-mode of action therapeutics in COVID19 therapyHow the lack of predictive power of preclinical cell and animal studies leads developments astray, vol 99
A talk someone posted recently by a doctor mentions that he treats patients with methylfolate and not folic acid
Still, it's important to tell your healthcare providers if youre drinking protein shakes
Supplies Important notes Always use a sterile syringe for each injection and dispose of it properly in a sharps container